RELENZA

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

ZANAMIVIR MICRONIZED

제공처:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC 코드:

J05AH01

약제 형태:

POWDER FOR INHALATION

구성:

ZANAMIVIR MICRONIZED 5 MG

관리 경로:

INHALATION

처방전 유형:

Required

Manufactured by:

GLAXO SMITH KLINE AUSTRALIA PTY LTD

치료 그룹:

ZANAMIVIR

치료 영역:

ZANAMIVIR

치료 징후:

Zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza A and B virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.

승인 날짜:

2017-03-26